Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
about
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of A166 in Patients With ...... or Having Amplified HER2 Gene
@en
type
label
Study of A166 in Patients With ...... or Having Amplified HER2 Gene
@en
prefLabel
Study of A166 in Patients With ...... or Having Amplified HER2 Gene
@en
P1050
P1476
A Phase I-II, FIH Study of A16 ...... sponding to Approved Therapies
@en
P3098
NCT03602079
P580
2018-07-16T00:00:00Z
P582
2020-10-01T00:00:00Z